JP2012514983A5 - - Google Patents

Download PDF

Info

Publication number
JP2012514983A5
JP2012514983A5 JP2011545540A JP2011545540A JP2012514983A5 JP 2012514983 A5 JP2012514983 A5 JP 2012514983A5 JP 2011545540 A JP2011545540 A JP 2011545540A JP 2011545540 A JP2011545540 A JP 2011545540A JP 2012514983 A5 JP2012514983 A5 JP 2012514983A5
Authority
JP
Japan
Prior art keywords
cell
composition
cells
pluripotent
cultured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011545540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012514983A (ja
JP5711149B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/020884 external-priority patent/WO2010083203A2/en
Publication of JP2012514983A publication Critical patent/JP2012514983A/ja
Publication of JP2012514983A5 publication Critical patent/JP2012514983A5/ja
Application granted granted Critical
Publication of JP5711149B2 publication Critical patent/JP5711149B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011545540A 2009-01-13 2010-01-13 非胚性幹細胞およびその使用 Expired - Fee Related JP5711149B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14420609P 2009-01-13 2009-01-13
US61/144,206 2009-01-13
PCT/US2010/020884 WO2010083203A2 (en) 2009-01-13 2010-01-13 Non-embryonic stem cells and uses thereof

Publications (3)

Publication Number Publication Date
JP2012514983A JP2012514983A (ja) 2012-07-05
JP2012514983A5 true JP2012514983A5 (enExample) 2012-10-18
JP5711149B2 JP5711149B2 (ja) 2015-04-30

Family

ID=42337124

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011545540A Expired - Fee Related JP5711149B2 (ja) 2009-01-13 2010-01-13 非胚性幹細胞およびその使用

Country Status (6)

Country Link
US (1) US8394630B2 (enExample)
EP (1) EP2387609B1 (enExample)
JP (1) JP5711149B2 (enExample)
CN (1) CN102333863A (enExample)
ES (1) ES2675553T3 (enExample)
WO (1) WO2010083203A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563307B2 (en) 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
US9422526B2 (en) 2011-06-14 2016-08-23 The University Of North Carolina At Chapel Hill Isolation, expansion and use of autologous pluripotent stem cells
TWI614340B (zh) 2011-09-28 2018-02-11 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
CN104822827B (zh) 2012-12-06 2020-01-21 干细胞生物科技公司 Lgr5+体干细胞
EP2746770A1 (en) 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
WO2014143383A1 (en) 2013-03-13 2014-09-18 Agilent Technologies, Inc. Transposome tethered to a gene delivery vehicle
JP2018501189A (ja) * 2014-11-19 2018-01-18 ステムバイオス テクノロジーズ,インコーポレイテッド 骨欠損を治療するための体性幹細胞
CA3002982A1 (en) 2015-10-22 2017-04-27 University Of Massachusetts Methods and compositions for treating metabolic imbalance in neurodegenerative disease
US11413356B2 (en) 2016-04-15 2022-08-16 University Of Massachusetts Methods and compositions for treating metabolic imbalance
TW202328432A (zh) * 2021-08-26 2023-07-16 清華大學 誘導全能性幹細胞及其製備方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US6916654B1 (en) 1992-06-29 2005-07-12 Oklahoma Medical Research Foundation Universal donor cells
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5591625A (en) 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US5908779A (en) 1993-12-01 1999-06-01 University Of Connecticut Targeted RNA degradation using nuclear antisense RNA
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
AU6869198A (en) 1997-03-25 1998-10-20 Morphogenesis, Inc. Universal stem cells
US20030161817A1 (en) 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
WO2002045506A1 (en) * 2000-10-26 2002-06-13 University Of Florida Drug screening system
CA2430653A1 (en) 2000-11-27 2002-08-08 Yissum Research Development Company Of The Hebrew University In Jerusalem Transfection of human embryonic stem cells
JP3977136B2 (ja) * 2001-05-22 2007-09-19 キヤノン株式会社 コイルユニット
US7422736B2 (en) 2002-07-26 2008-09-09 Food Industry Research And Development Institute Somatic pluripotent cells
WO2004042023A2 (en) 2002-11-01 2004-05-21 Five Prime Therapeutics, Inc. Stem cell libraries
EP1789540B9 (en) * 2004-09-03 2012-02-22 Moraga Biotechnology Inc. Non-embryonic totipotent blastomer-like stem cells and methods therefor
WO2006070370A2 (en) * 2004-12-29 2006-07-06 Hadasit Medical Research Services & Development Limited Stem cells culture systems
EP1962719A4 (en) * 2005-08-29 2011-05-04 Technion Res And Dev Of Foundation Ltd MEDIA FOR BREEDING STEM CELLS
US20080305079A1 (en) 2006-01-06 2008-12-11 Mount Sinai School Of Medicine Of New York University Myeloid Suppressor Cells, Methods For Preparing Them, and Methods For Using Them For Treating Autoimmunity
EP1991666A4 (en) * 2006-02-27 2009-06-10 Moraga Biotech Corp NON-EMBRYONIC TOTIPOTENT STEM CELLS OF BLASTOMERIC TYPE AND METHODS

Similar Documents

Publication Publication Date Title
JP2012514983A5 (enExample)
Zeng et al. Single-cell RNA sequencing resolves spatiotemporal development of pre-thymic lymphoid progenitors and thymus organogenesis in human embryos
Papadimitropoulos et al. Expansion of human mesenchymal stromal cells from fresh bone marrow in a 3D scaffold-based system under direct perfusion
Chihara et al. Differentiation and characterization of Tr1 cells
Abplanalp et al. Single-cell technologies to decipher cardiovascular diseases
Biel et al. Vascular smooth muscle cells from hypertensive patient-derived induced pluripotent stem cells to advance hypertension pharmacogenomics
Zou et al. CD4+ T cell immunity is dependent on an intrinsic stem-like program
Hu et al. Programming of the development of tumor-promoting neutrophils by mesenchymal stromal cells
JP2012516686A5 (enExample)
Mao et al. The molecular mechanisms of HLA-G regulatory function on immune cells during early pregnancy
Mohammadzadeh et al. Differentiation of spermatogonial stem cells by soft agar three-dimensional culture system
Alkhayal et al. Proteomic profiling of the first human dental pulp mesenchymal stem/stromal cells from carbonic anhydrase II deficiency osteopetrosis patients
Huang et al. Development and evaluation of IL‐6 overexpressing mesenchymal stem cells (MSCs)
Al Madhoun et al. Comparative proteomic analysis identifies EphA2 as a specific cell surface marker for Wharton’s jelly-derived mesenchymal stem cells
Jiang et al. Single-cell RNA-sequencing reveals interactions between endometrial stromal cells, epithelial cells, and lymphocytes during mouse embryo implantation
Corker et al. Organized chaos: deciphering immune cell heterogeneity’s role in inflammation in the heart
Ragni et al. Secreted factors and extracellular vesicles account for the immunomodulatory and tissue regenerative properties of bone-marrow-derived mesenchymal stromal cells for osteoarthritis
Fong et al. A serum-and feeder-free system to generate CD4 and regulatory T cells from human iPSCs
Primak et al. Novel immortalized human multipotent mesenchymal stromal cell line for studying hormonal signaling
Georgi et al. MicroRNA levels as prognostic markers for the differentiation potential of human mesenchymal stromal cell donors
Wang et al. Digital circulating tumor cells quantification
Scalise et al. Adult multipotent cardiac progenitor-derived spheroids: a reproducible model of in vitro cardiomyocyte commitment and specification
Lee et al. Renal cell carcinoma-infiltrating CD3low Vγ9Vδ1 T cells represent potentially novel anti-tumor immune players
Komarova et al. Cultured myoblasts derived from rat soleus muscle show altered regulation of proliferation and myogenesis during the course of mechanical unloading
Pennarossa et al. Generation of artificial blastoids combining miR-200-mediated reprogramming and mechanical cues